Integral Derivatives’s Zoetis ZTS Stock Holding History

Integral Derivatives’s Portfolio ZTS Stock Details ZTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-20,400	Closed	-$984K	–	1278
2015 Q2	$984K	Hold	20,400	–	–	0.03%	526
2015 Q1	$944K	Buy	+20,400	New	+$920K	0.02%	527

Other funds holding ZTS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Integral Derivatives's ZTS Position: Q4 2016 in Review

Integral Derivatives sold out of Zoetis (ZTS) in Q4 2016, closing a stake of 8,326 shares — an estimated $423K sold.

Integral Derivatives first reported a position in ZTS in Q3 2016 and held it in 1 quarter. The position peaked at $433K in Q3 2016. 692 funds tracked by Wall St. Rank hold ZTS as of Q4 2016.

Integral Derivatives reported no remaining Zoetis position as of Q4 2016 after selling out during the quarter.
Integral Derivatives sold 8,326 Zoetis shares in Q4 2016, an estimated $423K.
Integral Derivatives first reported a position in Zoetis in Q3 2016 and held it in 1 quarter.
Integral Derivatives's Zoetis position peaked at $433K in Q3 2016.
692 funds tracked by Wall St. Rank held Zoetis as of Q4 2016.

Based on Integral Derivatives's 13F filing for Q4 2016, filed 14 Feb 2017.